Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer is a research paper published in Cancer Discovery (2024). On theSindex it has a DataRank of 0.590. It has been cited 50 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.590
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Defense
Grant: W81XWH2110046
Conquer Cancer Foundation
Grant: 2019YIA
National Cancer Institute
Grant: T32CA203703
National Cancer Institute
Grant: UL1TR001873
U.S. Department of Defense
Grant: W81XWH2110539
National Cancer Institute
Grant: R01GM147365
National Institute of Dental and Craniofacial Research
Grant: T90 DE030859
U.S. Department of Defense
Grant: HT9425-24-1-0506
U.S. Department of Defense
Grant: W81XWH1910712
National Cancer Institute
Grant: R35CA242986
American Cancer Society
Grant: RP-19–, 181–, 01-RMC
National Cancer Institute
Grant: R35CA253175
National Cancer Institute
Grant: 1P50CA275741
U.S. Department of Defense
Grant: W81XWH-22-1-0833
U.S. Department of Defense
Grant: HT94252410252
National Cancer Institute
Grant: DP2 CA239597
Cancer Research UK
Grant: OT2CA278665
National Cancer Institute
Grant: 5R01CA227025
NCI
Grant: P50 CA097186
NCI NIH HHS
Grant: R01 CA227025
NCI NIH HHS
Grant: P30 CA082103
NCI NIH HHS
Grant: P50 CA275741
American Cancer Society (ACS)
Grant: RP-19-, 181-, 01-RMC
National Institutes of Health
Grant: 3UL1TR001873-07S1
Clinical and Translational Science Award
National Institutes of Health
Grant: 5R37CA263592-04
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
National Institutes of Health
Grant: 1T90DE030859-01
PORT (Portland Oral health Research Training)
National Institutes of Health
Grant: 3OT2CA278665-01S2
PROMINENT - UCSF
National Institutes of Health
Grant: 5T32CA203703-02
Molecular Oncology Training Program
National Institutes of Health
Grant: 5R01CA227025-04
Molecular Mechanisms of Castration Resistant Prostate Cancer Recurrence & Therapeutic Strategies
National Institutes of Health
Grant: 5R35CA253175-03
Determinants of response to cancer immunotherapy
National Institutes of Health
Grant: 3P30CA082103-21S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5P50CA097186-13
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment
National Institutes of Health
Grant: 5R35CA242986-05
Mechanisms of regulated translation control in cancer and its therapeutic implications
National Institutes of Health
Grant: 5R01GM147365-03
Characterizing phenotype-associated subpopulations from single-cell sequencing data
National Institutes of Health
Grant: 1DP2CA239597-01
A GENETIC INTERACTION MAP OF THE HUMAN NUCLEUS
Prostate Cancer Foundation
Prostate Cancer Foundation (PCF)
FWCI
14.02
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals